Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lymphoma Channel: NK/T-cell Lymphoma

Explore the latest updates and expert interviews

The Lymphoma Channel on VJHemOnc is supported by Janssen Pharmaceuticals (a Johnson & Johnson Company) and Takeda. The supporters have no influence over the production of the content.

Welcome to The NK/T-Cell Lymphoma Channel

VJHemOnc brings you all of the latest news in the field of NK/T-cell lymphoma, as presented by top experts. The NK/T-Cell Lymphoma Channel covers all of the state-of-the-art updates in NK/T-cell lymphoma from international congresses, including video interviews on presentations and abstracts, podcasts, and roundtable discussions with key opinion leaders.

Explore The NK/T-Cell Lymphoma Channel to learn about the latest advances in the field, including the use of novel therapies and combination regimens, and research identifying prognostic biomarkers.

View Aggressive T-Cell & NK-Cell Lymphoma Overview Page